Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: Role of MLC phosphorylation

Peiyi Wang, Alexander Dmitriyevich Verin, Anna Birukova, Lydia I. Gilbert-McClain, Keri Jacobs, Joe G N Garcia

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

NaF, a potent G protein activator and Ser/Thr phosphatase inhibitor, significantly increased albumin permeability and decreased transcellular electrical resistance (TER), indicating endothelial cell (EC) barrier impairment. EC barrier dysfunction induced by NaF was accompanied by the development of actin stress fibers, intercellular gap formation, and significant time-dependent increases in myosin light chain (MLC) phosphorylation. However, despite rapid, albeit transient, activation of Ca2+/calmodulin-dependent MLC kinase (MLCK), the specific MLCK inhibitor ML-7 failed to affect NaF-induced MLC phosphorylation, actin cytoskeletal rearrangement, and reductions in TER, suggesting a limited role of MLCK in NaF-induced EC activation. In contrast, strategies to reduce Rho (C3 exoenzyme or toxin B) or to inhibit Rho-associated kinase (Y-27632 or dominant/negative RhoK) dramatically reduced MLC phosphorylation and actin stress fiber formation and significantly attenuated NaF-induced EC barrier dysfunction. Consistent with this role for RhoK activity, NaF selectively inhibited myosin-specific phosphatase activity, whereas the total Ser/Thr phosphatase activity remained unchanged. These data strongly suggest that MLC phosphorylation, mediated primarily by RhoK, and not MLCK, participates in NaF-induced EC actin cytoskeletal changes and barrier dysfunction.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume281
Issue number6 25-6
StatePublished - Dec 31 2001
Externally publishedYes

Fingerprint

Sodium Fluoride
Myosin Light Chains
Endothelial Cells
Phosphorylation
Actins
Stress Fibers
Phosphotransferases
Electric Impedance
Phosphoric Monoester Hydrolases
Myosin-Light-Chain Phosphatase
Myosin-Light-Chain Kinase
rho-Associated Kinases
Calmodulin
GTP-Binding Proteins
Albumins
Permeability

Keywords

  • Actin cytoskeletal rearrangement
  • Myosin light chain
  • Myosin-specific phosphatase
  • Rho-associated kinase
  • Transendothelial electrical resistance

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology
  • Physiology (medical)

Cite this

Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction : Role of MLC phosphorylation. / Wang, Peiyi; Verin, Alexander Dmitriyevich; Birukova, Anna; Gilbert-McClain, Lydia I.; Jacobs, Keri; Garcia, Joe G N.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 281, No. 6 25-6, 31.12.2001.

Research output: Contribution to journalArticle

@article{2e70949b0a1343c5bae0eedee58c9870,
title = "Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: Role of MLC phosphorylation",
abstract = "NaF, a potent G protein activator and Ser/Thr phosphatase inhibitor, significantly increased albumin permeability and decreased transcellular electrical resistance (TER), indicating endothelial cell (EC) barrier impairment. EC barrier dysfunction induced by NaF was accompanied by the development of actin stress fibers, intercellular gap formation, and significant time-dependent increases in myosin light chain (MLC) phosphorylation. However, despite rapid, albeit transient, activation of Ca2+/calmodulin-dependent MLC kinase (MLCK), the specific MLCK inhibitor ML-7 failed to affect NaF-induced MLC phosphorylation, actin cytoskeletal rearrangement, and reductions in TER, suggesting a limited role of MLCK in NaF-induced EC activation. In contrast, strategies to reduce Rho (C3 exoenzyme or toxin B) or to inhibit Rho-associated kinase (Y-27632 or dominant/negative RhoK) dramatically reduced MLC phosphorylation and actin stress fiber formation and significantly attenuated NaF-induced EC barrier dysfunction. Consistent with this role for RhoK activity, NaF selectively inhibited myosin-specific phosphatase activity, whereas the total Ser/Thr phosphatase activity remained unchanged. These data strongly suggest that MLC phosphorylation, mediated primarily by RhoK, and not MLCK, participates in NaF-induced EC actin cytoskeletal changes and barrier dysfunction.",
keywords = "Actin cytoskeletal rearrangement, Myosin light chain, Myosin-specific phosphatase, Rho-associated kinase, Transendothelial electrical resistance",
author = "Peiyi Wang and Verin, {Alexander Dmitriyevich} and Anna Birukova and Gilbert-McClain, {Lydia I.} and Keri Jacobs and Garcia, {Joe G N}",
year = "2001",
month = "12",
day = "31",
language = "English (US)",
volume = "281",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 25-6",

}

TY - JOUR

T1 - Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction

T2 - Role of MLC phosphorylation

AU - Wang, Peiyi

AU - Verin, Alexander Dmitriyevich

AU - Birukova, Anna

AU - Gilbert-McClain, Lydia I.

AU - Jacobs, Keri

AU - Garcia, Joe G N

PY - 2001/12/31

Y1 - 2001/12/31

N2 - NaF, a potent G protein activator and Ser/Thr phosphatase inhibitor, significantly increased albumin permeability and decreased transcellular electrical resistance (TER), indicating endothelial cell (EC) barrier impairment. EC barrier dysfunction induced by NaF was accompanied by the development of actin stress fibers, intercellular gap formation, and significant time-dependent increases in myosin light chain (MLC) phosphorylation. However, despite rapid, albeit transient, activation of Ca2+/calmodulin-dependent MLC kinase (MLCK), the specific MLCK inhibitor ML-7 failed to affect NaF-induced MLC phosphorylation, actin cytoskeletal rearrangement, and reductions in TER, suggesting a limited role of MLCK in NaF-induced EC activation. In contrast, strategies to reduce Rho (C3 exoenzyme or toxin B) or to inhibit Rho-associated kinase (Y-27632 or dominant/negative RhoK) dramatically reduced MLC phosphorylation and actin stress fiber formation and significantly attenuated NaF-induced EC barrier dysfunction. Consistent with this role for RhoK activity, NaF selectively inhibited myosin-specific phosphatase activity, whereas the total Ser/Thr phosphatase activity remained unchanged. These data strongly suggest that MLC phosphorylation, mediated primarily by RhoK, and not MLCK, participates in NaF-induced EC actin cytoskeletal changes and barrier dysfunction.

AB - NaF, a potent G protein activator and Ser/Thr phosphatase inhibitor, significantly increased albumin permeability and decreased transcellular electrical resistance (TER), indicating endothelial cell (EC) barrier impairment. EC barrier dysfunction induced by NaF was accompanied by the development of actin stress fibers, intercellular gap formation, and significant time-dependent increases in myosin light chain (MLC) phosphorylation. However, despite rapid, albeit transient, activation of Ca2+/calmodulin-dependent MLC kinase (MLCK), the specific MLCK inhibitor ML-7 failed to affect NaF-induced MLC phosphorylation, actin cytoskeletal rearrangement, and reductions in TER, suggesting a limited role of MLCK in NaF-induced EC activation. In contrast, strategies to reduce Rho (C3 exoenzyme or toxin B) or to inhibit Rho-associated kinase (Y-27632 or dominant/negative RhoK) dramatically reduced MLC phosphorylation and actin stress fiber formation and significantly attenuated NaF-induced EC barrier dysfunction. Consistent with this role for RhoK activity, NaF selectively inhibited myosin-specific phosphatase activity, whereas the total Ser/Thr phosphatase activity remained unchanged. These data strongly suggest that MLC phosphorylation, mediated primarily by RhoK, and not MLCK, participates in NaF-induced EC actin cytoskeletal changes and barrier dysfunction.

KW - Actin cytoskeletal rearrangement

KW - Myosin light chain

KW - Myosin-specific phosphatase

KW - Rho-associated kinase

KW - Transendothelial electrical resistance

UR - http://www.scopus.com/inward/record.url?scp=0035216865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035216865&partnerID=8YFLogxK

M3 - Article

C2 - 11704544

AN - SCOPUS:0035216865

VL - 281

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6 25-6

ER -